DETECTION OF THE RISK OF ORAL DISEASES MEDIATED BY MICROORGANISMS

Patent number:
No items found.

Periodontal disease is a chronic inflammatory pathology caused by a dysbiosis of the subgingival dental plaque microbiota. It is characterized by inflammation, bleeding and progressive destruction of the soft tissue surrounding the tooth, the periodontal ligament, and, in advanced stages, the alveolar bone. It is not an isolated problem: it affects half of the population over 50 years and is associated with multiple systemic diseases such as Alzheimer's, diabetes, cardiovascular risk, premature births or certain types of cancer, among others. As a progressive pathology, early diagnosis is key to preventing irreversible damage, reducing the need for invasive treatments, planning check-ups and improving both quality of life and high long-term costs. However, current diagnostic solutions have limitations by focusing exclusively on identifying certain mutations with low prevalence, or certain bacterial species associated with periodontal disease, without considering the overall balance between potentially pathogenic microorganisms and healthy ones. Furthermore, those methods are slow, expensive and must be carried out by specialized personnel and facilities, which limits their applicability.

Countries:
Spain
Regions:
No items found.
Centers:
FISABIO, UNIVERSITAT DE VALENCIA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

The main advantages of the invention are: · Early and preventive detection: people at risk of developing periodontitis can be identified before the first symptoms appear, facilitating preventive interventions. · Functional biomarker: salivary antigenic glucan levels are directly measured, reflecting individual susceptibility to periodontitis. · Non-invasive: only salivary samples are required, collected through simple procedures. · Simplicity of use: it does not require specialized personnel or complex installations, which allows its implementation in conventional clinical environments, expediting decision-making. · Potential for personalized stratification: it allows prioritizing prevention in high-risk patients, optimizing resources and periodontal care plans The main application of the technology is in the health sector, as a periodontitis diagnosis and prognosis kit.

Comments

Other related patents

Health

In vitro synthesis of 3D cellular spheroids by ultrasonics

Countries
Spain
Know more
Health

IN VITRO METHOD FOR THE DIAGNOSIS OR PROGNOSIS OF NEURODEGENERATIVE DISORDERS

Countries
Spain
Know more
Health

ORAL SURGICAL RETRACTOR WITH PROTECTIVE ATTACHMENT FOR PARTICLE PROJECTION TECHNIQUES

Countries
Spain
Know more
Get back to patents directory